Organization - Institute of Cancer and Blood Diseases

The Institute of Cancer and Blood Diseases consists of four services:

  • Medical Oncology

    The Medical Oncology Service is made up of a team of healthcare professionals who carry out their work on the three fundamental levels of medical activity: cancer patient care, clinical and translational research, and teaching. These professionals are organized into the following solid diseases or tumors to ensure specialized and interdisciplinary care for each cancer patient:

    • Breast cancer
    • Digestive cancer
    • Skin cancer
    • Chest tumors
    • Genitourinary cancer
    • Gynecological cancer
    • Brain cancer
    • Head and neck cancer
    • Cancer of unknown origin
    • Strange tumors
  • Radiotherapy Oncology

    The Radiotherapy Oncology Service is made up of specialists with accredited experience and professionalism, both clinical and technological. Radiation oncology is a branch of clinical medicine that uses ionizing radiation, alone or in combination with other therapeutic modalities, to treat cancer and other non-neoplastic diseases. In the clinical sphere, the field of action of this specialty covers the study and treatment of cancer patients with diseases susceptible to radiation treatment.

  • Hematología

    The Hematology Service is made up of a large group of healthcare professionals whose main objective is to provide excellent medical care to patients with serious blood diseases (haemopathies), especially those that are neoplastic. The Service has gained extensive experience in addressing the following diseases:

    • Acute Leukemias
    • Lymphomas
    • Myeloma and Amyloidosis
    • Myeloproliferative neoplasms
    • Lymphoproliferative Syndromes
    • Myelodysplastic syndromes
    • Hematopoietic Progenitor Transplantation
    • Paroxysmal Nocturnal Hemoglobinuria
  • Hemotherapy and Hemostasis

    The Hemotherapy and Hemostasis Service is responsible for apheresis (the process of obtaining stem cells and hematopoietic progenitors), cell therapy, and the care of patients with altered blood clotting (hemostasis). It also includes diagnosis, treatment, prognosis and follow-up, as well as providing comprehensive care for patients on oral anticoagulant therapy. To achieve all this, it combines activity in emergency rooms, hospital interconsultations, and day hospital and outpatient consultations.

The ICAMS leads the Units of:

The Institute of Cancer and Blood Diseases carries out its activity using the following healthcare devices:

  • Hospitalization wards
  • Oncology and Hematology Day Hospital and Hemotherapy and Hemostasis
  • Home Care Unit
  • Palliative Care Support Unit
  • External consultations
  • Radiotherapy treatment room
  • Clinical Trials Unit